Omega Healthcare (OHI) CEO reports PIU vesting and OP Unit increases
Rhea-AI Filing Summary
Omega Healthcare Investors insider Form 4: Pickett C. Taylor, listed as Director and Chief Executive Officer, reported vesting conversions on 09/30/2025 that increased his holdings in the company and its operating partnership. Two sets of Profits Interest Units (PIUs) converted into OP Units (60,459 and 62,622 units) with a stated price of $0, increasing the reported OP Unit beneficial ownership levels to 388,506 and 325,884, respectively. Those OP Units also correspond to common stock equivalents: the conversions are shown as underlying Common Stock amounts that raise his reported common-equivalent holdings to 1,072,128 and 1,134,750. The filing notes the 2022–2024 performance-period vesting (25% per quarter) tied to Absolute and Relative Total Shareholder Return and explains OP Units are redeemable for cash equal to fair market value or, at the issuer's election, for shares. The form is signed by Meghan C. Lyons as attorney-in-fact on 10/01/2025.
Positive
- Clear disclosure of vesting mechanics tying PIU conversions to Absolute and Relative TSR for 2022–2024
- Quantified increase in beneficial ownership with exact PIU and OP Unit amounts (60,459 and 62,622) and resulting common-equivalent figures
Negative
- Potential dilution or redemption obligation is disclosed since OP Units are redeemable for cash equal to fair market value or for shares at the issuer's election
- No cash exercise paid (PIUs converted at $0), which may expand outstanding common-equivalent interests without direct insider cash investment
Insights
TL;DR: Routine performance-based vesting converted PIUs into OP Units and increased common-equivalent holdings; no purchase price was paid.
The reported transactions reflect scheduled vesting tied to the 2022–2024 TSR performance period, with 25% of PIUs vesting each quarter. Conversions are shown at a $0 price for PIUs to OP Units, consistent with contingent profit-interest mechanics rather than open-market purchases. The disclosure quantifies incremental beneficial ownership in both OP Units and common-equivalent shares, which can affect share count or redemption obligations depending on future elections by the issuer.
TL;DR: Vesting aligns executive compensation with multi-year TSR metrics; documentation clarifies redemption and conversion mechanics.
The filing documents compensation realization via PIU vesting subject to Absolute and Relative TSR metrics, indicating governance linkage between pay and shareholder returns. The explanation itemizes conversion mechanics and redemption rights for OP Units, providing important governance transparency about potential dilution or cash settlement outcomes. The presence of attorney-in-fact signature is consistent with procedural filing practices.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Exercise | Profits Interest Units | 60,459 | $0.00 | $0.00 |
| Exercise | Profits Interest Units | 62,622 | $0.00 | $0.00 |
| Exercise | OP Units | 60,459 | $0.00 | $0.00 |
| Exercise | OP Units | 62,622 | $0.00 | $0.00 |
Footnotes (4)
- F1. Represents Profits Interest Units ("PIUs") in OHI Healthcare Properties Limited Partnership (the "Operating Partnership"), of which the Issuer is the general partner. Each PIU represents a contingent right to receive one unit of limited partnership interest (an "OP Unit") in the Operating Partnership upon vesting and the satisfaction of certain tax-driven economic requirements.
- F2. Each OP Unit is redeemable at the election of the holder for cash equal to the then fair market value of one share of Issuer common stock, or at the Issuer's election, one share of Issuer common stock, subject to adjustment as set forth in the partnership agreement. The OP Units have no expiration date.
- F3. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Absolute Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
- F4. Represents 25% of the PIUs that vested into OP Units at the end of each calendar quarter in 2025 based on the Relative Total Shareholder Return for the 2022-2024 performance period, subject to continued employment and accelerated vesting under certain circumstances.
AI-generated analysis. How Rhea-AI works. Not financial advice.
